This Update on musculoskeletal infection presents a review of infection-related articles from 2017, from journals in the National Center for Biotechnology Information (NCBI) databases in the clinical areas of arthroplasty, orthopaedic oncology, orthopaedic trauma, pediatric orthopaedics, and hand surgery. Publications on infectious-disease topics that were relevant to orthopaedics, including antimicrobial prophylaxis (locally applied vancomycin powder), and the Centers for Disease Control and Prevention (CDC) guidelines on surgical site infection (SSI) prevention, published in 2017, were also reviewed.
Methods
Articles for review were selected by searching all journals in the NCBI databases for the infection-related terms "orthop(a)edic infection," "osteomyelitis," "bone infection," "implant infection," "fracture infection," "septic arthritis," and "biofilm" in combination with terms pertaining to clinical areas of interest: "arthroplasty," "orthop(a)edic oncology," "orthop(a)edic trauma," "fracture," "open fracture," "wound closure," "hand," "finger," "wrist," "child," "children," and "p(a)ediatric(s)."
We also searched for "vancomycin powder," "local vancomycin," "intra-wound vancomycin," "intra-operative vancomycin," "intra-site vancomycin," and "topical vancomycin" in all NCBI database journals without associated clinical areaof-interest search terms.
Reviewed were English-language papers that were published in 2017 and that reported infection as the topic of focus, the purpose of investigation, or the critical finding, as identified on a review of the title and abstract; we excluded papers that had infection as an incidental finding or were expert opinion.
We used our editorial discretion to identify articles that are pertinent and relevant to the readership. A total of 378 articles were identified; 137 are reviewed.
The vast majority of the studies were case reports and retrospective reviews, often without controls, that add observations and author experience to our knowledge base but do not provide strong evidence to direct practice. There were few prospective controlled trials or high-quality, large database studies with scientifically valid findings.
Antimicrobial Prophylaxis Locally Applied Vancomycin Powder
Recent retrospective series have demonstrated associations between the use of vancomycin powder prior to wound closure in spine surgery and reductions in SSI risk; prospective randomized controlled studies are still ongoing. The apparent success of topical vancomycin powder in preventing infection in spine surgery has raised the possibility of its benefit in other surgical fields, including those outside of orthopaedics. Additional studies have focused on the side-effects and impact of vancomycin powder use on the microbial etiology of infection.
In the spine literature, 2 retrospective studies noted associations between vancomycin powder use and lower infection risk among surgical patients 1, 2 . With respect to other orthopaedic disciplines, the use of vancomycin powder was associated with a lower overall infection rate in rib-based distraction surgery, although no difference in deep SSI was seen between those treated with and without intrawound vancomycin powder 3 . Likewise, the use of intraoperative vancomycin and tobramycin powder after pelvic and acetabular fracture fixation was not associated with lower infection risk after adjustment for intraoperative blood loss 4 . Vancomycin powder use and infection risk involving bones was also reported on in nonorthopaedic fields, including neurosurgery and cardiac Specialty Update has been developed in collaboration with the Board of Specialty Societies (BOS) of the American Academy of Orthopaedic Surgeons.
surgery; similar to the orthopaedic studies, these investigations were retrospective and noncontrolled. Among patients who underwent craniotomy, vancomycin powder use was associated with lower infection risk 5, 6 , while there was no association between vancomycin powder use and infection risk in cranioplasty 7 or sternal wound infection 8 . One animal study added to our understanding of vancomycin dose kinetics. In a rat femoral fracture model, the use of vancomycin powder after fixation led to high levels of vancomycin in soft tissue and bone for up to 48 hours, exceeding that which is achievable with systemic administration. At 48 hours, vancomycin levels were higher than needed to eradicate biofilm in muscle but not in bone; vancomycin was no longer detectable at 96 hours 9 . Several studies reported on the microbiological impact of vancomycin powder. For patients who developed infections despite the use of vancomycin powder, a greater frequency of infection involving gram-negative organisms was seen 10, 11 , suggesting the importance of obtaining specimens for culture and considering prior vancomycin powder exposure when planning empiric antimicrobial therapy.
CDC Guidelines on SSI Prevention
The CDC released 2017 guidelines for the prevention of SSI, with a section dedicated to prosthetic joint arthroplasty 12 . A total of 5,759 titles and abstracts were screened, and 170 studies were extracted. The recommendations covered a variety of topics, ranging from parenteral antimicrobial prophylaxis to anticoagulation (Table I) . With regard to prophylaxis using parenteral antimicrobials, the report included a strong recommendation that parenteral antimicrobials be administered prior to surgery so that a bactericidal concentration is established in the tissue and serum by the time of incision. Additionally, it was recommended that postoperative antimicrobial prophylaxis not be administered in clean and cleancontaminated procedures after incision closure, even if a drain is present. For nonparenteral antimicrobial prophylaxis, the evidence was inconclusive about the administration of intraoperative antimicrobial irrigation and antimicrobial dressings for preventing SSI. However, it was strongly recommended that antimicrobial powders, solutions, and ointments not be applied to the surgical incision to prevent SSI. Finally, there were weak recommendations that triclosan-coated sutures can be used to prevent SSI and that autologous platelet-rich plasma not be utilized to prevent SSI.
For patient management, glycemic control was strongly recommended for diabetic and nondiabetic patients, with target blood glucose levels of <200 mg/dL for both. There was no recommendation on preoperative hemoglobin A1C target levels and no recommendation on the ideal timing, duration, and delivery of glycemic control in the surgical period. Normothermia was strongly recommended, as was an increased fraction of inspired oxygen (FiO 2 ) during surgery and after extubation in patients with normal pulmonary function undergoing general anesthesia with endotracheal intubation. It was strongly recommended that patients bathe or shower with soap or an antiseptic agent prior to surgery. There was no recommendation on the number of applications and the use of chlorhexidine gluconate (CHG) prior to surgery. Additionally, the use of an alcohol-based surgical preparation was strongly recommended unless contraindicated. Weak recommendations included the intraoperative irrigation of deep and subcutaneous tissues with aqueous iodophor solution to reduce the risk of SSI. The guidelines stated that plastic adhesive drapes and microbial sealant may not be necessary to prevent SSI.
Specifically, for prosthetic joint arthroplasty 13, 14 , it was strongly recommended that the transfusion of blood products not be withheld to prevent SSI. However, the CDC did not provide guidelines about the harms and benefits of blood transfusion and the risk of SSI. There was also not enough evidence to draw conclusions about the administration of systemic corticosteroids and immunosuppressive therapies for the risk of SSI after prosthetic joint arthroplasty, or the optimal timing of intra-articular corticosteroid injections. Similarly, the report did not provide any guidelines with regard to anticoagulation, the use of orthopaedic surgical space suits, or the use of biofilm control agents to prevent SSI.
Total Joint Arthroplasty
The following section provides an overview of studies reporting on novel prevention techniques, advanced diagnosis, and treatment options for periprosthetic joint infection (PJI).
Prevention
Infection prevention was achieved in animal models in which titanium implants were coated with copper 15 , copper-titanium dioxide 16 , and magnesium 17 . Infection prevention was also achieved by administering active and passive immunization against Staphylococcus aureus in a rat model 18 . Preoperative supplementation with 25-hydroxyvitamin D3 in mice with 25-hydroxyvitamin D deficiency reduced infection risk by lowering bacterial and neutrophil burden 19 . In several Level-III and IV studies, authors reported on various strategies to prevent PJI. Total joint arthroplasty cases performed in the same operating room on the same day following a case with PJI were associated with an increased risk of infection 20 . In a different study, the authors found a reduced rate of intranasal S. aureus among patients in whom a topical povidone-iodine solution was applied prior to surgery 21 . Other authors advocated for a universal decolonization protocol involving 25 mL of 4% antimicrobial CHG for 5 days, instead of screening and decolonization with 5 days of intranasal mupirocin (twice daily) and chlorhexidine body wash 22 . Antimicrobial prophylaxis with clindamycin was associated with an increased infection risk compared with cloxacillin and cephalosporins 23 . The use of antimicrobial cement was effective in 
reducing the rate of infection after revision total knee arthroplasty but not primary total knee arthroplasty 24 . However, in 1 center in Spain, antimicrobial-loaded bone cement was found to reduce PJI in cemented hips and knees, resulting in a cost savings 25 . Intraoperative irrigation solutions, such as chlorhexidine, dilute povidone-iodine, and saline solution, were demonstrated to be effective and safe for infection prevention 26 . The use of surgical helmet systems, even with tape around the surgical gown cuffs, was not found to reduce the rate of wound contamination during surgery 27 . Similarly, laminar airflow ventilation demonstrated no associated reduction in SSI risk compared with modern operating room ventilation (positive pressure and high-volume and HEPA [high-efficiency particulate air] filtration that can lead to turbulent flow) 28 . In a different high-quality study, a reduction in airborne microorganisms using a device that delivers filtered airflow over the surgical wound reduced the rate of implant infections 29 . The application of a silver-impregnated dressing reduced SSI and acute PJI after total joint arthroplasty 30, 31 . Similarly, the use of closed incisional negative-pressure therapy reduced the rate of superficial infection, but it did not reduce the rate of deep infection 32 .
Diagnosis
Sonication with and without multiplex polymerase chain reaction (PCR) increased the sensitivity of organism identification in chronic PJI cases [33] [34] [35] [36] [37] [38] [39] [40] but was not more effective than tissue culture in identifying occult infection in aseptic revision 
WHAT' S N E W I N MUSCULOSKELETAL I N F E C T I O N total joint arthroplasty cases 41 . When sampling tissue, 3 to 4 tissue samples should be obtained when treating PJI to facilitate organism identification and antimicrobial management, in the experience of 2 institutions 42, 43 . Markers for PJI that were studied include presepsin 44 , adenosine deaminase 45 , procalcitonin 46, 47 , interleukin-6 (IL-6) 48 , leukocyte esterase [49] [50] [51] [52] , alpha-defensin [53] [54] [55] , D-dimer 56 , receptor activator of nuclear factor-kB ligand (RANKL), and osteoprotegerin 57 . Centrifugation of synovial fluid samples at 2,000 · gravity for 15 minutes improves leukocyte esterase testing, but testing should be performed on the top 2 mm of the centrifuged sample 58 . Two studies that evaluated the alphadefensin lateral flow assay reported high sensitivity and specificity 59, 60 . Additional optimal cutoffs for diagnosing acute PJI (between 1 and 3 weeks) were described and included synovial fluid white blood-cell (WBC) count (>11,200 cells/mL; 100% sensitivity, 98.9% specificity) and serum C-reactive protein (CRP) level (>34.9 mg/L; 100% sensitivity, 90.3% specificity) 61 .
Treatment
New retrospective data support the administration of preoperative antimicrobials to reduce the rate of subsequent PJI when performing revision arthroplasty procedures; culture yield for the detection of occult infection was similar to that among historical controls in whom preoperative antimicrobials were withheld 62 . When performing debridements, the use of methylene blue may help to visualize tissue that should be debrided 63, 64 . Additionally, a 3% acetic acid soak inhibits bacterial growth in vitro and may be safe as an irrigation solution, based on a level-IV study 65 . In a different study, poorer outcomes were reported when antimicrobial-impregnated calcium sulfate beads were utilized for treating acute hematogenous or acute postoperative PJI 66 . A PJI caused by a sensitive organism in a nonimmunocompromised patient with a well-fixed implant and no draining sinuses can be successfully treated with 1-stage exchange arthroplasty [67] [68] [69] . When partial 2-stage exchange arthroplasty after total hip arthroplasty was performed, whereby either the well-fixed acetabular cup or stem was retained, the success rate was reported as 81.3% among 16 patients 70 . When full 2-stage exchange arthroplasty was performed, similar infection control was achieved between culture-negative and culture-positive conditions 71 . Articulating spacers using metal-on-polyethylene yielded increased range of motion and fewer complications with similar infection control compared with other spacers 72 . Antimicrobials within cement spacers include vancomycin 73 , ceftazidime and fluconazole
74
, and teicoplanin 75 . However, caution must be taken when multiple antimicrobials are used [76] [77] [78] , as acute kidney injury can occur after the first stage, especially in patients with a higher body mass index (BMI), a lower hemoglobin level, and the presence of a comorbidity 79 . Additionally, bacterial genetic material can be identified on antimicrobial-loaded cement spacers following removal 80 . In vitro release data confirm that rifampin is released from polymethylmethacrylate (PMMA), although setting time is increased and a high dose (10% wt/wt) failed to eradicate infection in an animal model 81 .
Aspirating cement spacers between stages demonstrated low sensitivity (21%) and specificity for the presence of infection, and was not recommended to determine the timing of reimplantation 82 . Finally, in an interim analysis of an ongoing randomized study, the extended administration of antimicrobials reduces recurrent and/or new infection following 2-stage exchange arthroplasty when administered orally for 3 months postoperatively 83 . 86 . After therapeutic intravenous antimicrobials are initiated, surgical debridement is planned to minimize the bioburden of the wound. In a study that examined the bioburden of severe open tibial fractures, Bosse et al. found a correlation between quantitative bioburden at initial surgery and the risk of wound complications after definitive wound closure 87 . In another study, pulsatile lavage debridement of open fractures was associated with a higher infectious complication rate (relative risk of 2.70) 88 . There are various methods of surgical debridement, but Granick et al. noted that debridement with hydrojet or ultrasonic devices can result in spray distribution of particulate matter including bacteria, leaving the wound contaminated following the debridement 89 . Systemic antimicrobials have been extensively studied for open fractures and, more recently, local antimicrobials have been investigated in elective spine, total joint, and diabetic foot surgery. Carver et al. recommend the consideration of some combination of systemic and local antimicrobial coverage for high-grade open fractures 84 . For open fractures that require damage-control strategies and are not amenable to primary wound closure, negativepressure wound therapy placed at the time of the initial surgery was identified as an option to serve as a bridge to definitive wound coverage within 7 days, based on a summary of published reports 90 . The paradigm is evolving with regard to wound closure for open fractures. Primary wound closure for appropriate patients is being favored over leaving wounds open and planning for delayed wound closure. Two Level-I studies showed that the technique of wound closure can improve incisional perfusion, which was seen in the setting of ankle fracture with the Allgöwer-Donati suture technique 91 and in elective total knee arthroplasty with a running subcuticular closure 92 . A prospective study showed decreased nonunion and deep infection for grade-IIIA or lower open fractures with a wound deemed to be clean at the initial surgery 93 . Interestingly, a randomized clinical trial showed that a single preoperative dose of intravenous cefazolin, compared with placebo saline solution, did not reduce the risk of SSI within 30 days of the elective removal of hardware used for the treatment of foot, ankle, and lower-leg fractures 94 . The above orthopaedic trauma literature demonstrates the importance of soft-tissue viability, wound closure, antimicrobial strategies, and host status to achieve optimal results with closed and open fractures. Orthopaedic surgeons are now being challenged not only to consider which adjuncts to implement in fracture care but also to determine the optimal timing of these interventions.
Orthopaedic Trauma

Pediatric Orthopaedics
Basques and colleagues published an important study quantifying the incidence of infection in pediatric orthopaedic surgery 95 . Using the National Surgical Quality Improvement Program (NSQIP) pediatric database, the authors found that, of 8,975 patients who underwent 29 orthopaedic procedures, 143 (1.59%) experienced infections. Factors associated with infection included multiaxial external fixation, spinal fusion, polydactyly excision/reconstruction, benign excision (tibia), an American Society of Anesthesiologists (ASA) score of ‡3, BMI of ‡95th percentile, and impaired cognitive status 95 . Other studies highlighted infection risk after operative repair of a supracondylar humeral fracture; in 1 randomized study, there was no difference in infection risk whether pin care occurred daily, every other day, or weekly, although pain was more frequent with daily pin-site care 96 . From retrospective studies, postoperative antimicrobial use after supracondylar humeral fracture fixation and delay of surgery (>7 days) were not associated with infection risk 97, 98 . Kingella kingae continues to dominate the literature regarding microbial etiology in pediatric orthopaedics. In 1 case-control study, 65 children aged 6 to 48 months with osteoarticular infection were 38 times more likely to have oropharyngeal carriage of K. kingae DNA on specific PCR assay compared with 286 age-matched controls, providing additional support for the use of this test in diagnostic algorithms 99 . In 1 hospital, the proportion of admissions for osteoarticular infection due to Pneumococcus decreased by 35% since the introduction of pneumococcal conjugate vaccination, and decreased by 87% for osteoarticular disease caused by vaccine serotypes 100 . There were few articles on the diagnosis and management of osteoarticular infection. In a prospective multicenter surveillance study, Grote and colleagues compared 378 pediatric patients diagnosed with bacterial osteomyelitis and 279 with nonbacterial osteitis; the patients with osteomyelitis were more likely to have higher inflammatory markers and fever but had a shorter duration of symptoms 101 . One center reported on its experience with pediatric patients with bacteremic osteoarticular S. aureus infections 102 . Of 102 patients, 25% were transitioned to oral antimicrobial therapy at hospital discharge. These patients were not more likely to have complications related to their osteomyelitis than those on intravenous antimicrobials at discharge; however, the patients receiving oral antimicrobials were less likely to have methicillin-resistant S. aureus (MRSA) and had more rapid resolution of fever and decline in C-reactive protein than those discharged on intravenous antimicrobials. There was no difference in outcome for the 35 patients with MRSA infection according to the vancomycin trough (concentration of >15 versus £15 mg/mL) or duration of vancomycin; however, there was more nephrotoxicity in those who had higher trough values.
Hand Surgery
From the hand surgery literature during 2017, we reviewed 1 prospective Level-I clinical trial, 1 retrospective controlled cohort study, 2 large database analyses, 2 Level-IV systematic reviews, 13 retrospective case series, and 18 case reports. Atypical infection (18 articles) and tenosynovitis (8 articles) dominated the reported investigations.
Atypical infections caused by Mycobacterium tuberculosis (TB) [103] [104] [105] [106] [107] , nontuberculous mycobacteria (NTM) 104, [108] [109] [110] [111] [112] [113] , and fungi 104, [114] [115] [116] [117] were associated with delays in diagnosis, and the authors suggest a need for a heightened index of suspicion 103, 104, 110 , and when ordered, 2.4% of cultures were positive for acid-fast bacilli (AFB) and 5.3% were positive for fungi 104 . M. marinum is the most common NTM, but several other species were also investigated [108] [109] [110] 112, 113 . Clinical findings were described, and about half of the cases occurred in healthy hosts who had no apparent portal of entry or causative event 103, 107, 111 . Atypical infections in immunocompromised hosts were reported to receive longer antimicrobial treatment and more aggressive debridements; however, outcomes were similar to those of infections in immunocompetent hosts 112 .
Multiple observations related to tenosynovitis were presented in case reports and retrospective reviews. Causative agents included TB 103 , NTM 109 , fungi 115 , and bacteria 118, 119 . Pyogenic tenosynovitis was observed to have worse outcomes when the organism was Staphylococcus and when antimicrobial therapy was delayed 119 . Kanavel signs were observed to be sensitive but not specific 120 , and in 1 center's experience, when rice bodies were found in chronic tenosynovitis, the causative organism was often NTM, fungus, or unidentified 113 . In a Level-I prospective study of 322 patients with hand infections requiring surgical drainage, Sharma et al. found that diabetic patients with poor inpatient glucose control (average blood glucose of ‡180 mg/dL) required more repeat drainage procedures. Diabetic patients in general had more polymicrobial infections, osteomyelitis, septic arthritis, necrotizing fasciitis, and amputations than did nondiabetic patients 121 . Data on SSI risk was reported in 4 studies. In a Level-II study involving 7 years of Medicare data, Werner et al. reported 1,466 infections among 454,987 patients who underwent carpal tunnel release (0.32%). Positive associations were found between SSI risk and a young age, male sex, a BMI of >30 kg/m 2 , tobacco and alcohol use, peripheral vascular disease, chronic disease of the liver, kidney, or lung, and depression 122 . From a payer database, SSI risk following carpal tunnel release among 7,958 diabetic patients was higher with poor glycemic control 123 . In a Level-IV systematic review, the authors reported an SSI rate of 0.4% for carpal tunnel release performed in the office, procedure room, or emergency department to be the same rate as that when the procedure was performed in an operating room 124 . Buried Kirschner wires were observed to be associated with lower SSI risk than were wires left unburied in a retrospective review of 695 adult cases over 8 years Another study on fracture-related infections reported on 35 open Seymour distal phalangeal fractures among children; infection rates were lower when surgical debridement was performed within 24 hours and correct antimicrobial therapy was delivered 126 .
Conclusion
The 2017 literature on musculoskeletal infection presented data on a variety of topics, once again highlighting the multidisciplinary nature of infection. We reviewed the data from our individual and collective perspectives on biofilm biology, infectious diseases and antimicrobials, total joint arthroplasty, musculoskeletal trauma, and scientific validity and general orthopaedic understandings as well as drawing from career-long work in the prevention, diagnosis, treatment, and basic science of musculoskeletal and implantrelated infections. While the orthopaedic literature is nuanced by subspecialty, the goal was to present data from the respective fields within context, with the expectation that readers will draw from their own expertise to interpret our comments and cautiously carry lessons from one subspecialty to another.
Additional Studies of Interest
The authors reviewed a large number of recently published studies related to the musculoskeletal infection. In addition to articles cited already in the Update, 11 other articles were identified that were thought to be of interest to orthopaedists. A list of those titles is appended to this review after the standard bibliography. We have provided a brief commentary about each of the articles to help guide your further reading, in an evidence-based fashion, in this subspecialty area. 
